Cormorant Asset Management, LP - EPIRUS BIOPHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
Cormorant Asset Management, LP ownership history of EPIRUS BIOPHARMACEUTICALS IN
ValueSharesWeighting
Q1 2016$2,412,000
-12.9%
896,6000.0%0.36%
+9.7%
Q4 2015$2,770,000
-30.1%
896,6000.0%0.33%
-47.7%
Q3 2015$3,963,000
-22.6%
896,6000.0%0.63%
-7.0%
Q2 2015$5,120,000
-36.2%
896,6000.0%0.68%
-45.1%
Q1 2015$8,025,000
+1788.2%
896,600
+1095.5%
1.24%
+1778.8%
Q4 2014$425,00075,0000.07%
Other shareholders

There were no reported owners of EPIRUS BIOPHARMACEUTICALS IN in Q3 2023.

NameSharesValueWeighting ↓
View complete list of EPIRUS BIOPHARMACEUTICALS IN shareholders